Simplex Trading’s Mustang Bio MBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-2
Closed -$1K 10619
2022
Q1
$1K Sell
2
-17
-89% -$14K ﹤0.01% 10099
2021
Q4
$24K Buy
19
+12
+171% +$19.4K ﹤0.01% 8155
2021
Q3
$16K Hold
7
﹤0.01% 8613
2021
Q2
$16K Buy
+7
New +$17.2K ﹤0.01% 8771
2021
Q1
Sell
-1
Closed -$2.97K 6100
2020
Q4
$230K Buy
+1
New +$2.39K ﹤0.01% 4408
2020
Q3
Hold
0
5221
2019
Q4
Hold
0
-$4K 7674
2019
Q3
Sell
-1
Closed -$2.74K 6696
2019
Q2
$212K Buy
+1
New +$2.85K ﹤0.01% 3416

Other funds holding MBIO

Simplex Trading's MBIO Position: Q2 2023 in Review

Simplex Trading held its Mustang Bio (MBIO) position steady in Q2 2023 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #9535.

Simplex Trading first reported a position in MBIO in Q2 2019 and has held it in 10 quarters since. The position peaked at $155K in Q4 2020. 27 funds tracked by Wall St. Rank hold MBIO as of Q2 2023.

  • Simplex Trading held 0 shares of Mustang Bio worth $0 as of Q2 2023.
  • Simplex Trading left its Mustang Bio share count unchanged in Q2 2023.
  • Mustang Bio made up ﹤0.01% of Simplex Trading's portfolio in Q2 2023, its #9535 holding.
  • Simplex Trading first reported a position in Mustang Bio in Q2 2019 and has held it in 10 quarters since.
  • Simplex Trading's Mustang Bio position peaked at $155K in Q4 2020.
  • 27 funds tracked by Wall St. Rank held Mustang Bio as of Q2 2023.

Based on Simplex Trading's 13F filing for Q2 2023, filed 4 Aug 2023.